Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 04 symbols : NVS save search
Worldwide Gene Therapy Industry to 2027 - Players Include Amgen, Biogen and Novartis Among Others
Published: 2022-03-04 (Crawled : 21:00) - prnewswire.com
QURE | $4.82 3.21% 3.31% 380K
|
Health Technology
| Email alert
Add to watchlist
ABEO | News | $7.36 -2.77% -2.3% 160K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 5.4% 6.88% 0
|
Health Technology
| Email alert
Add to watchlist
BIIB | $194.11 -0.14% -0.15% 120
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.53 0.32% -1.11% 0
|
Manufacturing
| Email alert
Add to watchlist
AMGN | News | $271.91 1.11% 1.12% 560
|
Health Technology
| Email alert
Add to watchlist
ADAP | $1.01 3.41% 5.17% 100
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% 4.36% 160K
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.75 6.33% 43.47% 0
|
Health Technology
| Email alert
Add to watchlist
novartis gene therapy therapy
Global Dry Eye Syndrome Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-03-04 (Crawled : 20:00) - prnewswire.com
NVSEF | News | $95.11 5.4% 6.88% 0
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 0.52% -14.18% 0
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% 4.36% 160K
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
| Email alert
Add to watchlist
dry eye eye growth syndros
Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
Published: 2022-03-04 (Crawled : 14:30) - globenewswire.com
NVSEF | News | $95.11 5.4% 6.88% 0
|
Health Technology
|
| O: -3.34%
H: 0.0%
C: 0.0%
NVS | News | $95.12 0.81% 4.36% 160K
|
Health Technology
|
| O: -3.45%
H: 0.0%
C: 0.0%
novartis pos solutions
Worldwide Pain Management Drugs Industry to 2030 - Rise in Number of Cases of Chronic Disorders is Driving Growth
Published: 2022-03-04 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 0
|
Health Technology
|
| O: 3.37%
H: 0.0%
C: -3.7%
NVSEF | News | $95.11 5.4% 6.88% 0
|
Health Technology
|
| O: -3.34%
H: 0.0%
C: 0.0%
VTRS | News A | $11.25 -0.13% 4.1M
|
Health Technology
|
| O: -3.54%
H: 0.0%
C: 0.0%
PFE | News A | $26.26 1.0% 0.27% 110K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
NVS | News | $95.12 0.81% 4.36% 160K
|
Health Technology
|
| O: -3.45%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
|
| O: -4.03%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% 0.18% 3.8M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
order drug growth
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
SMFL | $4.35 29.2% 47.55% 4.2M
|
Manufacturing
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PROK | $2.72 33.33% 26.88% 20K
|
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SGD | $0.685 -1.71% 22.48% 2M
|
n/a
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.